Keeping an eye on $AMAT after an ~8% two-session drop despite record Q3 revenue and adjusted EPS, with Q4 guidance above consensus. The main risk is whether high expectations, near-term margin pressure and China exposure justify the valuation reset. There may still be details the market is pricing in that I haven’t caught yet; this is a watch, not a verdict.
220 views
0 Comments
Join the conversation with 500,000+ other investors 💸
Create an account to get access to everything Blossom has to offer!
📊 Personalized algorithm based on your investing style, experience level and interests
📈 Powerful portfolio and dividend tracking tools
👀 See what top creators and others in the community are investing in
